Carnegie Capital Asset Management, LLC Palatin Technologies Inc Transaction History

Carnegie Capital Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 14, 2019	SELL	$0.63 - $1.0 $18,900 - $30,000	-30,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	30,000	30,000 $13,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $16.7M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.